(19)
(11) EP 1 204 641 A1

(12)

(43) Date of publication:
15.05.2002 Bulletin 2002/20

(21) Application number: 00938919.8

(22) Date of filing: 14.06.2000
(51) International Patent Classification (IPC)7C07D 211/58, C07D 409/04, C07D 405/04, A61K 31/445
// (C07D409/04, 337:00), C07D211:00,(C07D405/04, 311:00), C07D211:00
(86) International application number:
PCT/GB0002/306
(87) International publication number:
WO 0078/718 (28.12.2000 Gazette 2000/52)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 17.06.1999 GB 9914024

(71) Applicant: AstraZeneca UK Limited
London W1Y 6LN (GB)

(72) Inventors:
  • WARAWA, Edward, John
    Wilmington, DE 19850-5437 (US)
  • MCLAREN, Charles, David
    Wilmington, DE 19850-5437 (US)
  • SIMON-BIERENBAUM, Richard, Elliot
    Wilmington, DE 19850-5437 (US)

(74) Representative: Wahlström, Christer et al
AstraZeneca AB,Global Intellectual Property
151 85 Södertälje
151 85 Södertälje (SE)

   


(54) 4-AMINOPIPERIDINE DERIVATIVES OF TETRAHYDRONAPHTHALENE, CHROMANS AND THIOCHROMANS